4//SEC Filing
Stanton Matthew 4
Accession 0001415889-24-001333
CIK 0001733294other
Filed
Jan 16, 7:00 PM ET
Accepted
Jan 17, 5:00 PM ET
Size
14.0 KB
Accession
0001415889-24-001333
Insider Transaction Report
Form 4
Stanton Matthew
CHIEF SCIENTIFIC OFFICER
Transactions
- Exercise/Conversion
Restricted Stock Units
2024-01-15−6,694→ 20,081 total→ Common Stock (6,694 underlying) - Exercise/Conversion
Common Stock
2024-01-15+7,437→ 241,976 total - Tax Payment
Common Stock
2024-01-15$1.91/sh−2,577$4,922→ 239,399 total - Exercise/Conversion
Common Stock
2024-01-15+6,694→ 246,093 total - Tax Payment
Common Stock
2024-01-15$1.91/sh−2,320$4,431→ 243,773 total - Exercise/Conversion
Restricted Stock Units
2024-01-15−7,437→ 0 total→ Common Stock (7,437 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents the right to receive one share of the company's common stock.
- [F2]On January 21, 2022, the reporting person was granted 59,500 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2022 and the remaining shares vesting in equal quarterly installments thereafter.
- [F3]On January 20, 2023, the reporting person was granted 26,775 restricted stock units. The shares underlying the restricted stock units vest over four years, with 25% of the shares vested on January 15, 2024 and the remaining shares vesting in equal quarterly installments thereafter.
Documents
Issuer
Generation Bio Co.
CIK 0001733294
Entity typeother
Related Parties
1- filerCIK 0001814198
Filing Metadata
- Form type
- 4
- Filed
- Jan 16, 7:00 PM ET
- Accepted
- Jan 17, 5:00 PM ET
- Size
- 14.0 KB